Harnessing The Power of Nature To Heal

products in various stages of development

patents filed and pending in the USA and internationally

Translational Science

For over eight years, our scientific research has driven significant advancements in regenerative medicine, progressing from the lab to clinical trials. At every stage of development, we put patients first and rely on robust scientific evidence. We conduct rigorous studies to ensure our products meet the highest standards of safety, efficacy, and quality.

Proteomics

In Vitro Genomics

In Vivo Animal Studies

Safety Assessments

Clinical Trials

01

Proteomics

We conducted in-depth proteomic discovery studies to identify and characterize the essential proteins within our product formulations. By examining these proteins and their interactions, we can precisely tailor our solutions to support the critical biological processes that drive tissue repair and regeneration.

02

In Vitro Genomics

We performed comprehensive genomic analyses to map gene expression profiles relevant to wound healing and tissue regeneration. This approach enables us to pinpoint the specific genes and pathways essential for effective repair, allowing us to refine and optimize our product lines for a variety of clinical applications.

03

In Vivo Studies

We carried out preclinical wound-healing investigations in porcine wound models to assess the safety, efficacy, and regenerative potential of our biomaterial. These studies bridge the gap between laboratory findings and real-world patient needs, ensuring our products meet stringent performance criteria before moving into clinical settings.

04

Safety Assessments

We executed a range of safety and toxicology assays to ensure that our regenerative materials meet rigorous biocompatibility standards. These evaluations underscore our commitment to patient safety and product reliability.

05

Clinical Trials

We are currently advancing through clinical trials to demonstrate the safety and efficacy of our biomaterial in human patients. These trials represent a critical milestone toward regulatory approval and broader clinical adoption.

Innovative Regenerative Technology

At RegenX Science, we have developed a proprietary regenerative biomaterial inspired by one of nature’s most remarkable healing organisms. This technology harnesses cutting-edge molecular biology and regenerative medicine techniques to create products that transform patient care. Our research-driven approach focuses on accelerating tissue regeneration and optimizing cellular repair for injuries and wounds. Our team is pioneering new solutions in wound healing and tissue regeneration to support faster, more effective recoveries. The bioactive microenvironment provided by our product promotes cell adhesion, proliferation, and differentiation, fostering robust tissue regrowth in damaged skin and open wounds. This approach jumpstarts the body’s natural healing processes, aiming to reduce scarring and improve outcomes for patients.

Our Partnerships

RegenX Science proudly holds partnerships with a number of leading researchers, institutions, and organizations. It is through this collective that we are afforded invaluable insight, research, and growth opportunities. Official Partners of RegenX Science:

Regenerating skin and its underlying structures could hasten wound healing and potentially even treat hair loss. Urodele collagen is type XII collagen, important in the salamander’s capacity to heal and regenerate.

Dr. Christine KO
Professor of Dermatology and Pathology at Yale University
quote

The use of urodele collagen extract derived from axolotl tissue is an exciting innovation, especially given its unique properties like scarless healing and antimicrobial activity…Overall, this research contributes significantly to the fields of regenerative medicine and dermatology, offering hope for more effective treatments in the future.

Dr. Arisa E. Ortiz
Director of Laser and Cosmetic Dermatology at the University of California, San Diego
quote

Connect with us today!